IN2015DN02877A - - Google Patents

Info

Publication number
IN2015DN02877A
IN2015DN02877A IN2877DEN2015A IN2015DN02877A IN 2015DN02877 A IN2015DN02877 A IN 2015DN02877A IN 2877DEN2015 A IN2877DEN2015 A IN 2877DEN2015A IN 2015DN02877 A IN2015DN02877 A IN 2015DN02877A
Authority
IN
India
Prior art keywords
formula
compound
xii
xiv
xiii
Prior art date
Application number
Other languages
English (en)
Inventor
Adam James Musgrave; Burrell
Padraig Mary; O'neill
Alan John; Pettman
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of IN2015DN02877A publication Critical patent/IN2015DN02877A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2877DEN2015 2012-10-15 2013-10-08 IN2015DN02877A (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261713761P 2012-10-15 2012-10-15
PCT/IB2013/059202 WO2014060900A1 (en) 2012-10-15 2013-10-08 Process for the preparation of voriconazole and analogues thereof

Publications (1)

Publication Number Publication Date
IN2015DN02877A true IN2015DN02877A (el) 2015-09-11

Family

ID=49641810

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2877DEN2015 IN2015DN02877A (el) 2012-10-15 2013-10-08

Country Status (24)

Country Link
US (2) US9388167B2 (el)
EP (1) EP2906555B1 (el)
JP (1) JP6180533B2 (el)
KR (1) KR101706488B1 (el)
CN (1) CN104884450B (el)
AU (1) AU2013333534B2 (el)
BR (1) BR112015007821B1 (el)
CA (1) CA2888127A1 (el)
CY (1) CY1118451T1 (el)
DK (1) DK2906555T3 (el)
ES (1) ES2615743T3 (el)
HK (1) HK1213891A1 (el)
HU (1) HUE031877T2 (el)
IL (1) IL238209A (el)
IN (1) IN2015DN02877A (el)
MX (1) MX358245B (el)
NZ (1) NZ706764A (el)
PL (1) PL2906555T3 (el)
PT (1) PT2906555T (el)
RU (1) RU2619928C2 (el)
SG (1) SG11201502237RA (el)
SI (1) SI2906555T1 (el)
WO (1) WO2014060900A1 (el)
ZA (1) ZA201501904B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ706764A (en) * 2012-10-15 2017-11-24 Pfizer Ireland Pharmaceuticals Process for the preparation of voriconazole and analogues thereof
CN106432198B (zh) * 2016-09-08 2022-10-21 浙江华海药业股份有限公司 一种制备伏立康唑拆分中间体的方法
CN112898273B (zh) * 2021-03-30 2022-05-31 海南锦瑞制药有限公司 伏立康唑的合成方法及应用
CN113185465B (zh) * 2021-05-26 2022-09-27 无锡捷化医药科技有限公司 一种4-乙基-5-氨基嘧啶的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9516121D0 (en) * 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
CA2590687C (en) * 2004-12-14 2013-09-10 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
US8067591B2 (en) 2005-01-10 2011-11-29 Agouron Pharmaceuticals, Inc. Pyrrolopyrazole, potent kinase inhibitors
KR100889937B1 (ko) * 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
WO2011045807A2 (en) * 2009-10-14 2011-04-21 Neuland Laboratories Ltd. A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
CN102827073A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN103814020B (zh) * 2011-06-17 2017-07-14 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
EP2900665B1 (en) * 2012-09-28 2018-01-03 Merck Sharp & Dohme Corp. Triazolyl derivatives as syk inhibitors
NZ706764A (en) * 2012-10-15 2017-11-24 Pfizer Ireland Pharmaceuticals Process for the preparation of voriconazole and analogues thereof
JO3383B1 (ar) 2013-03-14 2019-03-13 Lilly Co Eli مثبطات cdc7

Also Published As

Publication number Publication date
CA2888127A1 (en) 2014-04-24
CY1118451T1 (el) 2017-07-12
US20150239867A1 (en) 2015-08-27
US20160229842A1 (en) 2016-08-11
CN104884450A (zh) 2015-09-02
ES2615743T3 (es) 2017-06-08
WO2014060900A1 (en) 2014-04-24
SG11201502237RA (en) 2015-05-28
PT2906555T (pt) 2017-02-15
JP6180533B2 (ja) 2017-08-16
RU2619928C2 (ru) 2017-05-22
SI2906555T1 (sl) 2017-02-28
PL2906555T3 (pl) 2017-07-31
AU2013333534B2 (en) 2016-04-14
EP2906555A1 (en) 2015-08-19
JP2015536305A (ja) 2015-12-21
EP2906555B1 (en) 2016-12-14
US9388167B2 (en) 2016-07-12
MX2015004450A (es) 2015-06-24
BR112015007821B1 (pt) 2022-02-15
AU2013333534A1 (en) 2015-04-09
RU2015113741A (ru) 2016-12-10
HUE031877T2 (en) 2017-08-28
MX358245B (es) 2018-08-10
DK2906555T3 (en) 2017-02-06
IL238209A (en) 2017-07-31
IL238209A0 (en) 2015-06-30
KR20150055009A (ko) 2015-05-20
KR101706488B1 (ko) 2017-02-13
BR112015007821A2 (pt) 2017-07-04
US9499520B2 (en) 2016-11-22
HK1213891A1 (zh) 2016-07-15
ZA201501904B (en) 2017-01-25
CN104884450B (zh) 2017-03-29
NZ706764A (en) 2017-11-24

Similar Documents

Publication Publication Date Title
MX350892B (es) Síntesis de compuesto antiviral.
IN2012DN02751A (el)
MX2015002616A (es) Sintesis de bis(fluorosulfonil)imida.
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
IN2015DN01061A (el)
MX2015017870A (es) Procedimiento para producir 4-propargilado amino-benzoxazinonas.
PH12015501960B1 (en) Processes for the preparation of an apoptosis-inducing agent
MX349214B (es) Proceso para la fabricacion de benzoxazinonas.
MX360806B (es) Benzoxazinonas de carbamato.
NZ702935A (en) Process for making hydroxylated cyclopentylpyrimidine compounds
PH12018501642A1 (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
IN2014DN00144A (el)
MX2017017022A (es) Metodo para la sintesis de derivados de rapamicina.
IN2014DN09053A (el)
IN2015DN02877A (el)
MX363730B (es) Procedimiento para la preparacion de derivados de acido antranilico sustituidos.
IN2015DN00665A (el)
NZ720106A (en) A process for the preparation of regadenoson
MX350430B (es) Proceso para preparar compuestos acido 4-amino-5-bifenil-4-il-2-hi droximetil-2-metil-pentanoico.
MY168411A (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
GB2497841A (en) Subsea hydrocarbon production system
MX344910B (es) Proceso para la manufactura de ariloxiacetamidas.
CL2013001882A1 (es) Procedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios.
IN2012DN00346A (el)